|
1
|
Lee HY, Mohammed KA, Goldberg EP, Kaye F
and Nasreen N: Cisplatin loaded albumin mesospheres for lung cancer
treatment. Am J Cancer Res. 5:603–615. 2015.PubMed/NCBI
|
|
2
|
Wu DW, Lee MC, Hsu NY, Wu TC, Wu JY, Wang
YC, Cheng YW, Chen CY and Lee H: FHIT loss confers cisplatin
resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA
reduction. Oncogene. 34:25462015. View Article : Google Scholar
|
|
3
|
Zhang R, Wang R, Chen Q and Chang H:
Inhibition of autophagy using 3-methyladenine increases
cisplatin-induced apoptosis by increasing endoplasmic reticulum
stress in U251 human glioma cells. Mol Med Rep. 12:1727–1732.
2015.PubMed/NCBI
|
|
4
|
Jang JH, Kim YJ, Kim H, Kim SC and Cho JH:
Buforin IIb induces endoplasmic reticulum stress-mediated apoptosis
in HeLa cells. Peptides. 69:144–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shen Y, Yang J, Zhao J, Xiao C, Xu C and
Xiang Y: The switch from ER stress-induced apoptosis to autophagy
via ROS-mediated JNK/p62 signals: A survival mechanism in
methotrexate-resistant choriocarcinoma cells. Exp Cell Res.
334:207–218. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin YD, Chen S, Yue P, Zou W, Benbrook DM,
Liu S, Le TC, Berlin KD, Khuri FR and Sun SY: CAAT/enhancer binding
protein homologous protein-dependent death receptor 5 induction is
a major component of SHetA2-induced apoptosis in lung cancer cells.
Cancer Res. 68:5335–5344. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ron D and Hubbard SR: How IRE1 reacts to
ER stress. Cell. 132:24–26. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dong D, Ni M, Li J, Xiong S, Ye W, Virrey
JJ, Mao C, Ye R, Wang M, Pen L, et al: Critical role of the stress
chaperone GRP78/BiP in tumor proliferation, survival, and tumor
angiogenesis in transgene-induced mammary tumor development. Cancer
Res. 68:498–505. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Szegezdi E, Logue SE, Gorman AM and Samali
A: Mediators of endoplasmic reticulum stress-induced apoptosis.
EMBO Rep. 7:880–885. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kouroku Y, Fujita E, Tanida I, Ueno T,
Isoai A, Kumagai H, Ogawa S, Kaufman RJ, Kominami E and Momoi T: ER
stress (PERK/eIF2alpha phosphorylation) mediates the
polyglutamine–induced LC3 conversion, an essential step for
autophagy formation. Cell Death Differ. 14:230–239. 2007.
View Article : Google Scholar
|
|
11
|
Li MQ and Liu ZG: Dual role of autophagy
in chronic myeloid leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
23:583–586. 2015.In Chinese. PubMed/NCBI
|
|
12
|
Kim MO, Lee HS, Chin YW, Moon DO and Ahn
JS: Gartanin induces autophagy through JNK activation which
extenuates caspase-dependent apoptosis. Oncol Rep. 34:139–146.
2015.PubMed/NCBI
|
|
13
|
He J, Yu JJ, Xu Q, Wang L, Zheng JZ, Liu
LZ and Jiang BH: Downregulation of ATG14 by EGR1-MIR152 sensitizes
ovarian cancer cells to cisplatin-induced apoptosis by inhibiting
cyto–protective autophagy. Autophagy. 11:373–384. 2015. View Article : Google Scholar
|
|
14
|
Bao L, Jaramillo MC, Zhang Z, Zheng Y, Yao
M, Zhang DD and Yi X: Induction of autophagy contributes to
cisplatin resistance in human ovarian cancer cells. Mol Med Rep.
11:91–98. 2015.
|
|
15
|
Shen H, Zeng G, Sun B, Cai X, Bi L, Tang G
and Yang Y: A polysaccharide from Glycyrrhiza inflata Licorice
inhibits proliferation of human oral cancer cells by inducing
apoptosis via mitochondrial pathway. Tumour Biol. 36:4825–4831.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Köberle B, Tomicic MT, Usanova S and Kaina
B: Cisplatin resistance: Preclinical findings and clinical
implications. Biochim Biophys Acta. 1806:172–182. 2010.PubMed/NCBI
|
|
17
|
Chen J, Solomides C, Parekh H, Simpkins F
and Simpkins H: Cisplatin resistance in human cervical, ovarian and
lung cancer cells. Cancer Chemother Pharmacol. 75:1217–1227. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Horibe S, Matsuda A, Tanahashi T, Inoue J,
Kawauchi S, Mizuno S, Ueno M, Takahashi K, Maeda Y, Maegouchi T, et
al: Cisplatin resistance in human lung cancer cells is linked with
dysregulation of cell cycle associated proteins. Life Sci.
124:31–40. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu J, Yang Y and Wu J: Bcl-2 cleavages at
two adjacent sites by different caspases promote cisplatin-induced
apoptosis. Cell Res. 17:441–448. 2007.PubMed/NCBI
|
|
20
|
Sharma H, Sen S and Singh N: Molecular
pathways in the chemosensitization of cisplatin by quercetin in
human head and neck cancer. Cancer Biol Ther. 4:949–955. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei Q, Dong G, Franklin J and Dong Z: The
pathological role of Bax in cisplatin nephrotoxicity. Kidney Int.
72:53–62. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Z, Sun Y, Ren L, Huang Y, Cai Y, Weng
Q, Shen X, Li X, Liang G and Wang Y: Evaluation of a curcumin
analog as an anti-cancer agent inducing ER stress-mediated
apoptosis in non-small cell lung cancer cells. BMC Cancer.
13:4942013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu SH, Hang LW, Yang JS, Chen HY, Lin HY,
Chiang JH, Lu CC, Yang JL, Lai TY, Ko YC, et al: Curcumin induces
apoptosis in human non-small cell lung cancer NCI-H460 cells
through ER stress and caspase cascade- and mitochondria-dependent
pathways. Anticancer Res. 30:2125–2133. 2010.PubMed/NCBI
|
|
24
|
Moir RD, Gross DA, Silver DL and Willis
IM: SCS3 and YFT2 link transcription of phospholipid biosynthetic
genes to ER stress and the UPR. PLoS Genet. 8:e10028902012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hetz C: The UPR as a survival factor of
cancer cells: More than folding proteins? Leuk Res. 33:880–882.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin Y, Wang Z, Liu L and Chen L: Akt is
the downstream target of GRP78 in mediating cisplatin resistance in
ER stress-tolerant human lung cancer cells. Lung Cancer.
71:291–297. 2011. View Article : Google Scholar
|
|
27
|
Cui WY, Liu Y, Zhu YQ, Song T and Wang QS:
Propofol induces endoplasmic reticulum (ER) stress and apoptosis in
lung cancer cell H460. Tumour Biol. 35:5213–5217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lan D, Wang W, Zhuang J and Zhao Z:
Proteasome inhibitor-induced autophagy in PC12 cells overexpressing
A53T mutant α-synuclein. Mol Med Rep. 11:1655–1660. 2015.
|
|
29
|
Zang Y, Thomas SM, Chan ET, Kirk CJ,
Freilino ML, DeLancey HM, Grandis JR, Li C and Johnson DE: The next
generation proteasome inhibitors carfilzomib and oprozomib activate
prosurvival autophagy via induction of the unfolded protein
response and ATF4. Autophagy. 8:1873–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tallóczy Z, Jiang W, Virgin HW IV, Leib
DA, Scheuner D, Kaufman RJ, Eskelinen EL and Levine B: Regulation
of starvation- and virus-induced autophagy by the eIF2alpha kinase
signaling pathway. Proc Natl Acad Sci USA. 99:190–195. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu M, Ma S, Liu M, Hou Y, Liang B, Su X
and Liu X: Synergistic killing of lung cancer cells by cisplatin
and radiation via autophagy and apoptosis. Oncol Lett. 7:1903–1910.
2014.PubMed/NCBI
|
|
32
|
Bao LJ, Jaramillo MC, Zhang ZB, Zheng YX,
Yao M, Zhang DD and Yi XF: Nrf2 induces cisplatin resistance
through activation of autophagy in ovarian carcinoma. Int J Clin
Exp Pathol. 7:1502–1513. 2014.PubMed/NCBI
|
